Sexual Dysfunction clinical trials

Explore recruiting sexual dysfunction clinical trials.

Recruiting sexual dysfunction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sexual Dysfunction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Transdermal estradiol and exercise in mitigating adverse effects of androgen deprivation therapy for prostate cancer radiation therapy (ESTRACISE)

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Genitourinary Syndrome and Female Sexual Dysfunction: Effect of topical glyceryl trinitrate on female genital function in the peri- and postmenopause – a Pilot Study

Austria

Human Pharmacology (Phase I)- Other EU CTIS Study details

An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)

Sweden, Hungary, France, Portugal, Slovakia, Poland +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pharmacological treatment of compulsive sexual behaviour disorder

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pharmacological treatment of compulsive sexual behaviour disorder

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK)

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sexual Dysfunction trials by city

Sexual Dysfunction in Toronto Sexual Dysfunction in Vancouver Sexual Dysfunction in Montreal Sexual Dysfunction in Calgary Sexual Dysfunction in Edmonton Sexual Dysfunction in Ottawa Sexual Dysfunction in Winnipeg Sexual Dysfunction in Quebec City Sexual Dysfunction in Hamilton Sexual Dysfunction in Kitchener Sexual Dysfunction in London Sexual Dysfunction in Halifax Sexual Dysfunction in New York Sexual Dysfunction in Los Angeles Sexual Dysfunction in Chicago Sexual Dysfunction in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease